Recombinant Streptococcus pneumoniae sialidase 33A1 produced by Escherichia coli, is responsible for hydrolyzing terminal N- or O-acetylneuraminic acids which are α2,3-, α2,6-, α2,8- linked to oligosaccharides, polysaccharides, mucopolysaccharides, glycoproteins, and glycolipids.
Expression System
Escherichia coli
Species
Streptococcus pneumoniae
Concentration
0.5 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Sialidases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Streptococcus pneumoniae sialidase 33A1 can be used in clinical chemistry, glycobiology, and carbohydrate research. It has the ability to hydrolyze glycoprotein human alpha-1 (AGP), and sialic acids.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
